286 related articles for article (PubMed ID: 34942633)
1. Broadly neutralizing antibodies target a haemagglutinin anchor epitope.
Guthmiller JJ; Han J; Utset HA; Li L; Lan LY; Henry C; Stamper CT; McMahon M; O'Dell G; Fernández-Quintero ML; Freyn AW; Amanat F; Stovicek O; Gentles L; Richey ST; de la Peña AT; Rosado V; Dugan HL; Zheng NY; Tepora ME; Bitar DJ; Changrob S; Strohmeier S; Huang M; García-Sastre A; Liedl KR; Bloom JD; Nachbagauer R; Palese P; Krammer F; Coughlan L; Ward AB; Wilson PC
Nature; 2022 Feb; 602(7896):314-320. PubMed ID: 34942633
[TBL] [Abstract][Full Text] [Related]
2. Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
Wang W; Song HS; Keller PW; Alvarado-Facundo E; Vassell R; Weiss CD
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593038
[TBL] [Abstract][Full Text] [Related]
3. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
4. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
5. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
[TBL] [Abstract][Full Text] [Related]
6. Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.
Hu W; Chen A; Miao Y; Xia S; Ling Z; Xu K; Wang T; Xu Y; Cui J; Wu H; Hu G; Tian L; Wang L; Shu Y; Ma X; Xu B; Zhang J; Lin X; Bian C; Sun B
Virology; 2013 Jan; 435(2):320-8. PubMed ID: 23084424
[TBL] [Abstract][Full Text] [Related]
7. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.
Guthmiller JJ; Han J; Li L; Freyn AW; Liu STH; Stovicek O; Stamper CT; Dugan HL; Tepora ME; Utset HA; Bitar DJ; Hamel NJ; Changrob S; Zheng NY; Huang M; Krammer F; Nachbagauer R; Palese P; Ward AB; Wilson PC
Sci Transl Med; 2021 Jun; 13(596):. PubMed ID: 34078743
[TBL] [Abstract][Full Text] [Related]
8. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.
Iba Y; Fujii Y; Ohshima N; Sumida T; Kubota-Koketsu R; Ikeda M; Wakiyama M; Shirouzu M; Okada J; Okuno Y; Kurosawa Y; Yokoyama S
J Virol; 2014 Jul; 88(13):7130-44. PubMed ID: 24719430
[TBL] [Abstract][Full Text] [Related]
9. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.
Zhu X; Guo YH; Jiang T; Wang YD; Chan KH; Li XF; Yu W; McBride R; Paulson JC; Yuen KY; Qin CF; Che XY; Wilson IA
J Virol; 2013 Dec; 87(23):12619-35. PubMed ID: 24049169
[TBL] [Abstract][Full Text] [Related]
10. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
11. A highly conserved neutralizing epitope on group 2 influenza A viruses.
Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
[TBL] [Abstract][Full Text] [Related]
12. The influenza virus hemagglutinin head evolves faster than the stalk domain.
Kirkpatrick E; Qiu X; Wilson PC; Bahl J; Krammer F
Sci Rep; 2018 Jul; 8(1):10432. PubMed ID: 29992986
[TBL] [Abstract][Full Text] [Related]
13. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
14. Influenza vaccination strategies targeting the hemagglutinin stem region.
Fukuyama H; Shinnakasu R; Kurosaki T
Immunol Rev; 2020 Jul; 296(1):132-141. PubMed ID: 32542739
[TBL] [Abstract][Full Text] [Related]
15. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.
Krammer F; Palese P
J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353
[TBL] [Abstract][Full Text] [Related]
16. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
17. A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve.
Fu Y; Zhang Z; Sheehan J; Avnir Y; Ridenour C; Sachnik T; Sun J; Hossain MJ; Chen LM; Zhu Q; Donis RO; Marasco WA
Nat Commun; 2016 Sep; 7():12780. PubMed ID: 27619409
[TBL] [Abstract][Full Text] [Related]
18. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.
Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; García-Sastre A; Albrecht RA
J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585
[TBL] [Abstract][Full Text] [Related]
19. The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
Nagashima K; Dzimianski JV; Han J; Abbadi N; Gingerich AD; Royer F; O'Rourke S; Sautto GA; Ross TM; Ward AB; DuBois RM; Mousa JJ
J Immunol; 2022 Jul; 209(1):5-15. PubMed ID: 35697384
[TBL] [Abstract][Full Text] [Related]
20. A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Powell TJ; Rijal P; McEwen-Smith RM; Byun H; Hardwick M; Schimanski LM; Huang KA; Daniels RS; Townsend ARM
J Gen Virol; 2019 Mar; 100(3):431-445. PubMed ID: 30714896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
